Genomed Spólka Akcyjna reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was PLN 5.78 million compared to PLN 5.03 million a year ago. Net loss was PLN 0.144948 million compared to net income of PLN 0.168599 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28 PLN | 0.00% | 0.00% | -6.04% |
1st Jan change | Capi. | |
---|---|---|
-6.04% | 92.11L | |
+16.59% | 4.49TCr | |
-10.62% | 3.78TCr | |
+40.49% | 3.76TCr | |
+29.92% | 3.13TCr | |
-9.78% | 2.74TCr | |
+12.34% | 2.63TCr | |
+41.53% | 1.41TCr | |
+31.49% | 1.25TCr | |
-7.40% | 1.12TCr |
- Stock Market
- Equities
- GEN Stock
- News Genomed Spólka Akcyjna
- Genomed Spólka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2023